Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BMF-219 |
Trade Name | |
Synonyms | BMF219|BMF 219 |
Drug Descriptions |
BMF-219, is an irreversible menin inhibitor, which potentially decreases expression of KRAS, MYC, and BCL2, and reduces tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2665; Blood (2021) 138 (Supplement 1): 4318.). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C185864 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BMF-219 | BMF-219 | 1 | 2 |
BMF-219 + Venetoclax | BMF-219 Venetoclax | 0 | 0 |